Abstract
This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
Keywords: Tuberculosis, Mycobacterium tuberculosis, anti-tubercular drugs, drug targets, structure-activity relationship
Mini-Reviews in Medicinal Chemistry
Title: Recent Developments in Antitubercular Drugs
Volume: 8 Issue: 14
Author(s): Pallavi Ahirrao
Affiliation:
Keywords: Tuberculosis, Mycobacterium tuberculosis, anti-tubercular drugs, drug targets, structure-activity relationship
Abstract: This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
Export Options
About this article
Cite this article as:
Ahirrao Pallavi, Recent Developments in Antitubercular Drugs, Mini-Reviews in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/138955708786786516
DOI https://dx.doi.org/10.2174/138955708786786516 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleuroscopy Early Experience in the Exudative Pleural Effusion of Unknown Etiology
Current Respiratory Medicine Reviews Exploring and Prioritization of Mobile-Based Self-Management Strategies for HIV Care
Infectious Disorders - Drug Targets The role of interleukin 35 in atherosclerosis
Current Pharmaceutical Design A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Synthesis, admetSAR Predictions, DPPH Radical Scavenging Activity, and Potent Anti-mycobacterial Studies of Hydrazones of Substituted 4-(anilino methyl) benzohydrazides (Part 2)
Current Computer-Aided Drug Design Synthesis and Anti-tubercular Activity of 6-(<i>4</i>-Chloro/Methyl-phenyl)-4- Arylidene-4,5-dihydropyridazin-3(2<i>H</i>)-one Derivatives Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery In vitro Synthesis, Structure Elucidation, and Antioxidant Properties of Platinum(IV)-hydrazide Complexes: Molecular Modeling of Free- Hydrazides Suggested as Potent Lipoxygenase Inhibitor
Medicinal Chemistry Targeting Th2 Cells in Asthmatic Airways
Current Drug Targets - Inflammation & Allergy Association of Folate Level in Blood with the Risk of Schizophrenia
Combinatorial Chemistry & High Throughput Screening Reversal of Multi-Drug Resistance in Staphylococcus aureus by Natural Product-Way Forward
Letters in Drug Design & Discovery Polysaccharides to Combat Viruses (COVID-19) and Microbes: New updates
Current Molecular Pharmacology The β-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets
Current Medicinal Chemistry Radiomics and Diagnostic CT-MRI
Current Medical Imaging Bacterial RNA Polymerase Inhibitors: An Organized Overview of their Structure, Derivatives, Biological Activity and Current Clinical Development Status
Current Medicinal Chemistry The Genus Glycosmis [Rutaceae]: A Comprehensive Review on its Phytochemical and Pharmacological Perspectives
The Natural Products Journal Predicting Drugs and Proteins in Parasite Infections with Topological Indices of Complex Networks: Theoretical Backgrounds, Applications and Legal Issues
Current Pharmaceutical Design Explicit Treatment of Water Molecules in Protein-Ligand Docking
Current Computer-Aided Drug Design Synthesis and Biological Evaluation of Some Novel 10H-Phenothiazines, their Sulfones and Nucleosides as Possible Antimicrobial Agents
Current Bioactive Compounds Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
Infectious Disorders - Drug Targets Circulating MicroRNAs as Biomarkers for Inflammatory Diseases
MicroRNA